Featured Research

from universities, journals, and other organizations

Allergy-Producing Cells Are Also "Do-Gooders," Helping Stave Off Infections

Date:
July 7, 1999
Source:
Duke University
Summary:
Researchers at Duke University Medical Center have discovered that mast cells -- the same cells responsible for the miseries of allergy - also recognize harmful bacteria such as Salmonella and dangerous strains of E. coli and alert the immune system to destroy the bacteria.

DURHAM, N.C. - Researchers at Duke University Medical Center have discovered that mast cells -- the same cells responsible for the miseries of allergy - also recognize harmful bacteria such as Salmonella and dangerous strains of E. coli and alert the immune system to destroy the bacteria.

The researchers say the discovery, which appears in the July 6 issue of the Proceedings of the National Academy of Science, may lead to new ways to fight infections, particularly in patients whose immune systems are compromised during an organ transplant or HIV infection.

The research is supported by grants from the National Institutes of Health and the Medical Research Council.

"For years people have wondered why we have mast cells when they seem to do nothing but cause misery for people with allergy and asthma," said microbiologist Soman Abraham, lead investigator of the study. "Now we've shown that the mast cell has a crucial role in identifying potentially dangerous bacteria and alerting the immune system to destroy them."

The much maligned mast cells lie just beneath the surface of virtually all body tissues that have contact with the outside world: the skin, gut, nasal passages, lung and urinary tract. For years mast cells seemed only to be a sort of cry-wolf cell that overreact to the inhalation of substances as benign as pollen grains and release a flood of inflammatory molecules and histamine - the bane of allergy sufferers.

But Abraham and his colleagues discovered a more subtle but powerful role for mast cells. The researchers found a molecule called CD48 on the mast cell surface. CD48 recognizes a protein called FimH on the tips of hair-like projections on many infectious bacteria. This CD48-FimH connection triggers mast cells to alert the immune system by releasing a substance called tumor necrosis factor alpha (TNF-a), which is a type of early warning system of infection, Abraham said.

"We are bombarded with bacteria every day," Abraham said. "In healthy people, mast cells seem to help clear the body of bacteria quickly, so that you don't even know you've been infected. Only when you get such a huge dose of bacteria that the mast cells can't cope or when your immune system is compromised do the bacteria gain a foothold."

Typically, mast cells are not activated by the beneficial bacteria that inhabit the gut, because such bacteria colonize the surface of the intestinal lining, he said. Only when bacteria become invasive, burrowing into the gut lining, are the mast cells alerted.

The Duke scientists' discovery also appears to clear up a mystery about the function of the CD48 protein. Although CD48 was discovered more than 10 years ago as a protein that appears on the surface of some white blood cells such as mast cells, its biological role has not been clearly defined.

In their experiments, Abraham and his colleagues showed that antibodies to CD48 blocked mast cells from recognizing bacteria and stopped the mast cells from releasing the signaling molecule TNF-a in the presence of bacteria. This finding led the researchers to conclude that CD48 is a specific receptor on mast cells that recognizes bacteria and triggers the release of TNF-a, which alerts the immune system to destroy the bacteria.

The researchers will now try to find ways to beef up the mast cells' ability to fight bacteria in people with weakened immune systems, such as people infected by HIV or who are taking anti-rejection drugs following organ transplantation. Such a strategy might be a way to avoid overuse of traditional antibiotic treatment, said Abraham.

"Now that we know that CD48 is the important trigger, we can target treatments that would trip that trigger to help boost the immune system's ability to fight infection in people with immune deficiency," he added.

Ravi Malaviya, Zhimin Gao, Krishnan Thankavel and P. Anton van der Merwe also contributed to the research.


Story Source:

The above story is based on materials provided by Duke University. Note: Materials may be edited for content and length.


Cite This Page:

Duke University. "Allergy-Producing Cells Are Also "Do-Gooders," Helping Stave Off Infections." ScienceDaily. ScienceDaily, 7 July 1999. <www.sciencedaily.com/releases/1999/07/990707073205.htm>.
Duke University. (1999, July 7). Allergy-Producing Cells Are Also "Do-Gooders," Helping Stave Off Infections. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/1999/07/990707073205.htm
Duke University. "Allergy-Producing Cells Are Also "Do-Gooders," Helping Stave Off Infections." ScienceDaily. www.sciencedaily.com/releases/1999/07/990707073205.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins